| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_efd2173ae246894566a1e2ddf6852c4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0e155777b418fec8d45a825424d5e9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_534523571cdc90350c6a93f306a0839c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J47-028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 |
| filingDate |
2017-10-26^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_243072cb441fd4430a78280708d92d1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_012c0727ffbf520839c8039fec0fc1ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_add15bf674b098f3bf1484a3feb808cc |
| publicationDate |
2018-05-03^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2018081329-A1 |
| titleOfInvention |
Purification process for removal of tyrosine sulfation antibody variants; purified compositions |
| abstract |
The present invention relates to purified antibody and antigen-binding fragment compositions that lack sulfated tyrosine on one or more tyrosine residues in the immunoglobulin chains. Purification methods for removing sulfated tyrosine variants from antibody and antigen-binding fragment compositions are also provided. |
| priorityDate |
2016-10-28^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |